Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Empathy and Communication Training Program for Psychiatric Nurse Specialists in Saudi Arabia (ECTP) (ECTP)

12. November 2026 aktualisiert von: Amer Ahmed Amer Alammari, Lincoln University College

Effectiveness of an Empathy and Communication Training Program on Nurse-Reported Therapeutic Engagement Among Psychiatric Nurse Specialists in Saudi Arabia: A Two-Site Quasi-Experimental Study With an Explanatory Sequential Mixed-Methods Design

This study tests whether a five-day Empathy and Communication Training Program (ECTP) helps psychiatric nurse specialists in Saudi Arabia engage better with their patients. Good relationships between nurses and patients are central to mental health care, but structured training in empathy and communication is limited in Saudi psychiatric hospitals.

The ECTP is a face-to-face program of five two-hour sessions (10 hours in total). It covers empathy and communication, the work environment, language and cultural barriers, and emotional preparedness. Sessions use short lectures, role-play, case discussions and group reflection.

The study took place at two psychiatric hospitals. Nurses at the Eradah Complex for Mental Health in Dammam took the ECTP. Nurses at the Eradah Hospital for Mental Health in Madinah attended their usual hospital training sessions instead. Participants were not randomly assigned. The hospital they worked in decided which group they joined.

Nurses at both hospitals completed a 15-item questionnaire about therapeutic engagement before and after the training period. After the program, 15 nurses from the Dammam group were interviewed about how the training affected their work and what barriers remained.

The study aims to find out whether nurses' self-reported therapeutic engagement improves after the ECTP compared with usual training, and to understand nurses' own experiences of the program.

Studienübersicht

Detaillierte Beschreibung

BACKGROUND The relationship between nurse and patient is a core part of effective psychiatric care. Empathy, active listening, trust and clear communication are its main building blocks. In Saudi Arabia, language and cultural differences within a diverse nursing workforce, together with heavy workloads, can make these relationships harder to build. Structured empathy and communication training for psychiatric nurses is scarce in Saudi hospitals and has rarely been evaluated.

DESIGN This is an explanatory sequential mixed-methods study. The first phase is a quasi-experimental, pre-test/post-test, non-equivalent control-group study. The second phase is a descriptive qualitative study using semi-structured interviews. Participants were assigned to conditions by hospital site rather than individually, because individual randomisation was not feasible (different institutional protocols, geographical separation, the need to keep routine clinical operations running) and to limit contamination between groups.

SETTING AND PARTICIPANTS The intervention site was the Eradah Complex for Mental Health in Dammam (Eastern Region). The control site was the Eradah Hospital for Mental Health in Madinah (Western Region). Both are tertiary psychiatric hospitals providing inpatient, outpatient and addiction services. All eligible psychiatric nurse specialists providing direct patient care at each site were invited to take part. Written informed consent was obtained from all participants.

INTERVENTION The ECTP was developed by the principal investigator with a panel of three experts in psychiatric nursing and nursing education. It was delivered 2 to 6 August 2026 by nurse educators and psychiatric nurse trainers with at least five years of experience in mental health education. Day 1 covered orientation and baseline assessment. Day 2 covered empathy and communication, Day 3 the work environment and training, Day 4 language and cultural barriers, and Day 5 emotional preparedness. Methods included short lectures, role-play, case-based discussion and reflective group activities.

COMPARATOR Control-group nurses attended usual institutional training sessions of their own choosing, lasting 5 to 8 hours, and submitted certificates of attendance. Because this content varied and could include material related to communication or de-escalation, the comparator is usual institutional training and not a no-training control.

DATA COLLECTION Participants completed a paper-based questionnaire in hospital classrooms during working hours, under researcher supervision. The 15-item questionnaire was adapted from the Therapeutic Engagement Questionnaire (used with permission from the developers at Kingston University London) and has four domains: empathy and communication, work environment and training, language and cultural barriers, and emotional preparedness. Items are rated 1 to 5. Three barrier-worded items are reverse-scored so that higher scores always mean more favourable engagement. The questionnaire was given at baseline and immediately after Day 5 for the intervention group, and at an equivalent interval for the control group. Participants created anonymous codes so that their before and after responses could be matched.

After the program, a purposive sample of intervention-group nurses took part in face-to-face interviews of 35 to 55 minutes, audio-recorded with separate written consent. Interviews continued until thematic saturation (15 participants).

SAMPLE SIZE A power analysis (independent-samples t-test, two-tailed, alpha 0.05, power 0.80, Cohen's d 0.50) gave a minimum of 64 participants per group. After finite population correction and a 15% allowance for attrition, the target samples were 66 (Dammam) and 61 (Madinah).

ANALYSIS Quantitative data are analysed with paired and independent-samples t-tests, with non-parametric tests as robustness checks, and with analysis of covariance using baseline score as the covariate. Effect sizes are reported as Cohen's d and partial eta squared. Interview transcripts are analysed with thematic analysis (Braun and Clarke) in NVivo. Quantitative and qualitative findings are integrated using a joint display.

REGISTRATION This study was registered retrospectively, after data collection had finished.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

154

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Al Madinah Province
      • Madinah, Al Madinah Province, Saudi-Arabien, 42363
        • Eradah Hospital for Mental Health
    • Eastern Province
      • Dammam, Eastern Province, Saudi-Arabien, 32253
        • Eradah Complex for Mental Health

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Currently employed at one of the two study hospitals (Eradah Complex for Mental Health, Dammam, or Eradah Hospital for Mental Health, Madinah)
  • Psychiatric nurse specialist assigned to a psychiatric ward or an outpatient psychiatric or addiction clinic, with direct patient care responsibilities
  • At least six months of psychiatric nursing experience
  • Written informed consent

Exclusion Criteria:

  • Less than six months of psychiatric nursing experience
  • Currently on extended leave (for example maternity leave, sick leave or other long-term absence)

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Versorgungsforschung
  • Zuteilung: Nicht randomisiert
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: ECTP (Dammam)

Psychiatric nurse specialists at the Eradah Complex for Mental Health, Dammam, who took part in the five-day ECTP. They completed the therapeutic engagement questionnaire at baseline (Day 1) and immediately after Day 5. Fifteen of these nurses were interviewed afterwards.

Structured five-day, face-to-face training program, two hours per day (10 hours in total), delivered 2-6 August 2026 by nurse educators and psychiatric nurse trainers. Day 1: orientation and baseline assessment. Day 2: empathy and communication. Day 3: work environment and training. Day 4: language and cultural barriers. Day 5: emotional preparedness. Methods: short lectures, role-play, case-based discussion and reflective group activities.

Aktiver Komparator: Usual institutional training (Madinah)

Psychiatric nurse specialists at the Eradah Hospital for Mental Health, Madinah, who did not receive the ECTP and attended usual institutional training sessions of their choice (5-8 hours). They completed the same questionnaire at baseline and at an equivalent interval later.

Training sessions of the nurse's own choosing, offered as part of routine hospital education (for example on substance use, personality disorders or trauma-informed care), lasting 5-8 hours. Nurses submitted certificates of attendance.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in overall nurse-reported patient therapeutic engagement (PTE) score
Zeitfenster: Baseline (Day 1) and immediately after Day 5 of the program (August 2026)

Overall score on the 15-item nurse-reported PTE questionnaire, adapted from the Therapeutic Engagement Questionnaire. Each item is rated from 1 (strongly disagree) to 5 (strongly agree). Items 5, 9 and 10 describe barriers and are reverse-scored (6 minus the original value). The overall score is the mean of all 15 items (range 1 to 5). Higher scores mean more favourable therapeutic engagement. The outcome is the change from baseline to post-test, compared between the intervention group (Dammam) and the control group (Madinah).

Baseline (Day 1) and immediately after Day 5 of the program (August 2026)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Empathy and Communication domain score
Zeitfenster: Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Mean of items 1 to 3 of the PTE questionnaire (range 1 to 5). Higher scores mean more favourable engagement.

Baseline (Day 1) and immediately after Day 5 of the program (August 2026).
Change in Work Environment and Training domain score
Zeitfenster: Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Mean of items 4 to 8 of the PTE questionnaire (range 1 to 5), with item 5 reverse-scored. Higher scores mean more favourable engagement.

Baseline (Day 1) and immediately after Day 5 of the program (August 2026).
Change in Language and Cultural Barriers domain score
Zeitfenster: Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Mean of items 9 and 10 of the PTE questionnaire (range 1 to 5), both reverse-scored. Higher scores mean fewer perceived barriers.

Baseline (Day 1) and immediately after Day 5 of the program (August 2026).
Change in Emotional Preparedness domain score
Zeitfenster: Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Mean of items 11 to 15 of the PTE questionnaire (range 1 to 5). Higher scores mean more favourable engagement.

Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. März 2026

Primärer Abschluss (Tatsächlich)

15. August 2026

Studienabschluss (Tatsächlich)

18. August 2026

Studienanmeldedaten

Zuerst eingereicht

21. Oktober 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

21. Oktober 2026

Zuerst gepostet (Tatsächlich)

28. Oktober 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

17. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

12. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

De-identified questionnaire data (anonymous participant codes, demographic variables and item-level responses) will be shared with qualified researchers on reasonable request to the corresponding author. Interview transcripts and audio recordings will not be shared, to protect participant confidentiality.

IPD-Sharing-Zeitrahmen

Data will be available after publication of the main results, on request, for 5 years.

IPD-Sharing-Zugriffskriterien

Requests should be sent by email to the corresponding author (amer.phdscholar@lincoln.edu.my) with a brief description of the intended use. Access is subject to ethics requirements and to the licensing and permission requirements of the original Therapeutic Engagement Questionnaire.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren